Monday, February 25, 2013 « Back
Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference

JERUSALEM--(BUSINESS WIRE)--Feb. 25, 2013-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the 2013 RBC Capital Markets Global Healthcare Conference. Jon Congleton, SVP, Global Medicines Group, will present on Wednesday, February 27, 2013.

What:

  Teva Presentation at the 2013 RBC Capital Markets Global Healthcare Conference
 

Who:

Jon Congleton, SVP, Global Medicines Group
 

When:

Wednesday, February 27 2013 at 1:30 PM (EST)

 

Where:

www.tevapharm.com or

http://www.veracast.com/webcasts/rbc/healthcare2013/38211345.cfm

 

How:

Live over the Internet – log on to the Web at the address above and register for the
event (approximately 10 minutes before). An archive of the webcast will be available
on Teva’s website.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $20.3 billion in net revenues in 2012.

Source: Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.
IR:
Kevin C. Mannix
United States
215-591-8912
or
Kristen Frank
United States
215-591-8908
or
Tomer Amitai
Israel
972 (3) 926-7656
or
PR:
Hadar Vismunski-Weinberg
Israel
972 (3) 926-7687
or
Denise Bradley
United States
215-591-8974